Претраживање
Приказ резултата 1-10 од 164
Properties and potential application of modern adsorbents in formulation of solid drug delivery systems / Karakteristike i potencijalna primena savremenih adsorbenata u formulaciji nosača lekovitih supstanci
(Savez farmaceutskih udruženja Srbije, Beograd, 2016)
In latest years, many natural and synthetic solid carriers attract increasing attention, due to theirs biocompatibility, acceptable ecological and toxicological properties, possible modification of physico-chemical properties, ...
Pharmaceutical care in the treatment of deep vein thrombosis / Farmaceutska zdravstvena zaštita u terapiji duboke venske tromboze
(Savez farmaceutskih udruženja Srbije, Beograd, 2013)
Anticoagulation therapy is commonly used in deep vein thrombosis (DVT) prophylaxis associated with surgical interventions and in treatment of patients with DVT, atrial fibrillation and prosthetic heart valves. Long-term ...
Nanomaterials in cosmetic products: Functionality and safety issues / Nanomaterijali u kozmetičkim proizvodima - opravdanost primene i bezbednost
(Savez farmaceutskih udruženja Srbije, Beograd, 2013)
Nanomaterials in cosmetic products include particles of active ingredients (AI) (nanocrystals, nanoparticles) (e.g., ultrafine/nanoparticles titanium dioxide, zinc oxide, silver, gold) as well as a variety of nanocarriers ...
Motivation of students' population blood donors at the University of Belgrade: Faculty of Pharmacy / Motivisanost studenata davalaca krvi na Farmaceutskom fakultetu Univerziteta u Beogradu
(Institut za transfuziju krvi Srbije, Beograd, 2013)
Introduction: Insufficient blood donation is almost generally recognized as a world-wide problem being followed by a trend in an ever decreasing number of collected blood units. Aims: (i) Analysis of voluntary blood donation ...
Diazepam-loaded parenteral nanoemulsions: Physicochemical characterization and in vitro release study / Parenteralne nanoemulzije diazepama - fizičkohemijska karakterizacija i in vitro ispitivanje brzine oslobađanja
(Savez farmaceutskih udruženja Srbije, Beograd, 2016)
The aim of the present study was to develop parenteral nanoemulsions containing increasing content of oil phase (20, 30 and 40%, w/w of medium-chain triglycerides-soybean oil mixture at 4:1 ratio), stabilized by ...
Biomarkers of prehipertension / Biomarkeri prehipertenzije
(Savez farmaceutskih udruženja Srbije, Beograd, 2013)
Prehypertension, which was defined as a systolic blood pressure (SBP) between 120 and 139 mmHg or a diastolic blood pressure (DBP) between 80 and 89 mmHg is shown to be associated with a twofold higher risk of cardiovascular ...
Biologics: Pharmaceutical-technological specificities / Biološki lekovi - farmaceutsko-tehnološke specifičnosti
(Savez farmaceutskih udruženja Srbije, Beograd, 2012)
The field of pharmaceutical biotechnology is developing rapidly. For those working in the field of pharmacy and pharmaceutical sciences, completely new and novel techniques and product appear at a rapid pace, with an almost ...
Novel delivery systems with nonsteroidal anti-inflammatory drugs / Savremeni farmaceutski oblici nesteroidnih antiinflamatornih lekova
(Savez farmaceutskih udruženja Srbije, Beograd, 2016)
Chronic use of oral nonsteroidal anti-inflammatory drugs (NSAIDs) is associated with increased risk of serious gastrointestinal side effects. Therefore, recent trends in the development of NSAIDs aim to reduce the incidence ...
Herbal medicinal products in chronic venous disease / Primena biljnih lekovitih proizvoda kod hronične venske bolesti
(Savez farmaceutskih udruženja Srbije, Beograd, 2013)
In treatment of chronic venous disease (CVD) venoactive drugs (VADs) are used. They represent a heterogeneous group of drugs of synthetic (ie. calcium dobesilate, naftazone, and benzarone) or natural origin. Venoactive ...
Adverse side-effects of biological agents: Hypersensitivity reactions / Neželjeni efekti bioloških lekova - reakcije preosetljivosti
(Savez farmaceutskih udruženja Srbije, Beograd, 2014)
Clinical use of various biological agents (protein-based products derived from biological sources, such as bacteria, fungi or mammalian cells) have greatly improved the treatment of a wide variety of diseases in humans. ...